Related references
Note: Only part of the references are listed.Immunodiagnosis and Immunotherapeutics Based on Human Papillomavirus for HPV-Induced Cancers
Zhen Dong et al.
FRONTIERS IN IMMUNOLOGY (2021)
First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers
Fenne L. Komdeur et al.
MOLECULAR THERAPY (2021)
A commentary on the development of engineered phage as therapeutics
Anne M. L. Barnard et al.
DRUG DISCOVERY TODAY (2021)
Engineered T Cell Therapy for Gynecologic Malignancies: Challenges and Opportunities
Yifan Xu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Development of HPV16,18,31,45 E5 and E7 peptides-based vaccines predicted by immunoinformatics tools
Ali Namvar et al.
BIOTECHNOLOGY LETTERS (2020)
Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: A systematic review and meta-analysis
C. Marchetti et al.
CANCER TREATMENT REVIEWS (2020)
Current status of therapeutic HPV vaccines
Katharine T. Clark et al.
GYNECOLOGIC ONCOLOGY (2020)
Recurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review Study
Shitanshu Uppal et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
One Small Dose, One Giant Leap for CRISPR Gene Editing
Alex Philippidis
HUMAN GENE THERAPY (2020)
Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer: Review of the Literature and Perspectives of Clinical Research
Angiolo Gadducci et al.
ANTICANCER RESEARCH (2020)
2019 IUSTI-Europe guideline for the management of anogenital warts
R. Gilson et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Safety and Efficacy of CTX001 in Patients with Transfusion-Dependent β-Thalassemia and Sickle Cell Disease: Early Results from the Climb THAL-111 and Climb SCD-121 Studies of Autologous CRISPR-CAS9-Modified CD34+Hematopoietic Stem and Progenitor Cells
Haydar Frangoul et al.
BLOOD (2020)
Significance of serum antibodies against HPV E7, Hsp27, Hsp20 and Hp91 in Iranian HPV-exposed women
Amitis Ramezani et al.
BMC INFECTIOUS DISEASES (2019)
The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-up
Diane M. Harper et al.
GYNECOLOGIC ONCOLOGY (2019)
Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus
Zheng Quan Toh et al.
INFECTION AND DRUG RESISTANCE (2019)
A Comparison of Plasmid DNA and mRNA as Vaccine Technologies
Margaret A. Liu
VACCINES (2019)
CRISPR screens are feasible in TP53 wild-type cells
Kevin R. Brown et al.
MOLECULAR SYSTEMS BIOLOGY (2019)
Systemic Delivery of CRISPR/Cas9 Targeting HPV Oncogenes Is Effective at Eliminating Established Tumors
Luqman Jubair et al.
MOLECULAR THERAPY (2019)
In silico/In vivo analysis of high-risk papillomavirus L1 and L2 conserved sequences for development of cross-subtype prophylactic vaccine
Ali Namvar et al.
SCIENTIFIC REPORTS (2019)
Double-slit photoelectron interference in strong-field ionization of the neon dimer
Maksim Kunitski et al.
NATURE COMMUNICATIONS (2019)
Adjuvant treatment of anogenital warts with systemic interferon: a systematic review and meta-analysis
Lukas Westfechtel et al.
SEXUALLY TRANSMITTED INFECTIONS (2018)
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 28, pg 72, 2017)
C. Marth et al.
ANNALS OF ONCOLOGY (2018)
Therapeutic HPV vaccines
Gemma Hancock et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2018)
Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical model
Alex Allen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Immune check-point in cervical cancer
F. De Felice et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
LASER treatment for women with high-grade vaginal intraepithelial neoplasia: A propensity-matched analysis on the efficacy of ablative versus excisional procedures
Giorgio Bogani et al.
LASERS IN SURGERY AND MEDICINE (2018)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Dynamics of HPV viral loads reflect the treatment effect of photodynamic therapy in genital warts
Zhili Hu et al.
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2018)
Human papilloma virus: global research architecture assessed by density-equalizing mapping
Dörthe Brüggmann et al.
Oncotarget (2018)
Survival Nomograms after Curative Neoadjuvant Chemotherapy and Radical Surgery for Stage IB2-IIIB Cervical Cancer
Claudia Marchetti et al.
CANCER RESEARCH AND TREATMENT (2018)
Treatment of latent or subclinical Genital HPV Infection with 5-aminolevulinic acid-based photodynamic therapy
Zhili Hu et al.
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2018)
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials
M. Arbyn et al.
EXPERT REVIEW OF VACCINES (2018)
Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer
Alexander Melamed et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Genome and Epigenome Editing in Mechanistic Studies of Human Aging and Aging-Related Disease
Cia-Hin Lau et al.
GERONTOLOGY (2017)
Self-administered interventions for anogenital warts in immunocompetent patients: a systematic review and meta-analysis
Ricardo Niklas Werner et al.
SEXUALLY TRANSMITTED INFECTIONS (2017)
Investigational drugs for the treatment of cervical cancer
Fabio Barra et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Increased expression of PD-L1 by the human papillomavirus 16 E7 oncoprotein inhibits anticancer immunity
Chaoqi Liu et al.
MOLECULAR MEDICINE REPORTS (2017)
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
Michiru Nishita et al.
SCIENTIFIC REPORTS (2017)
Cervical intraepithelial neoplasia: screening and management
A. Mitra et al.
BRITISH JOURNAL OF HOSPITAL MEDICINE (2016)
GTL001, A Therapeutic Vaccine for Women Infected with Human Papillomavirus 16 or 18 and Normal Cervical Cytology: Results of a Phase I Clinical Trial
Pierre Van Damme et al.
CLINICAL CANCER RESEARCH (2016)
Current state in the development of candidate therapeutic HPV vaccines
Andrew Yang et al.
EXPERT REVIEW OF VACCINES (2016)
Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies
P. Vici et al.
EXPERT REVIEW OF VACCINES (2016)
Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research
Sung-Jong Lee et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2016)
Validation of Serological Antibody Profiles Against Human Papillomavirus Type 16 Antigens as Markers for Early Detection of Cervical Cancer
Dolores Azucena Salazar-Pina et al.
MEDICINE (2016)
Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis
Maria Kyrgiou et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis
Maria Kyrgiou et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Perspectives for therapeutic HPV vaccine development
Andrew Yang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2016)
CRISPRdirect: software for designing CRISPR/Cas guide RNA with reduced off-target sites
Yuki Naito et al.
BIOINFORMATICS (2015)
In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR/Cas9
Shuai Zhen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Sinecatechins (Polyphenon E) ointment for treatment of external genital warts and possible future indications
Eggert Stockfleth et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2014)
Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases
Seung Woo Cho et al.
GENOME RESEARCH (2014)
Immunomodulatory effects of EGCG fraction of green tea extract in innate and adaptive immunity via T regulatory cells in murine model
Chao-Lin Kuo et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2014)
Disruption of HPV16-E7 by CRISPR/Cas System Induces Apoptosis and Growth Inhibition in HPV16 Positive Human Cervical Cancer Cells
Zheng Hu et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Episomal Expression of Truncated Listeriolysin O in LmddA-LLO-E7 Vaccine Enhances Antitumor Efficacy by Preferentially Inducing Expansions of CD4+FoxP3- and CD8+ T Cells
Zhisong Chen et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Imiquimod for anogenital warts in non-immunocompromised adults
Carlos F. Grillo-Ardila et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Successful therapeutic vaccination with integrase defective lentiviral vector expressing nononcogenic human papillomavirus E7 protein
Felicia Grasso et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Simultaneous Detection, Genotyping, and Quantification of Human Papillomaviruses by Multicolor Real-Time PCR and Melting Curve Analysis
Yiqun Liao et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
HPV16 E5 peptide vaccine in treatment of cervical cancer in vitro and in vivo
Shu-jie Liao et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2013)
Acceptability of the Human Papillomavirus Vaccine Among Urban Adolescent Males
Baudelio Gutierrez et al.
AMERICAN JOURNAL OF MENS HEALTH (2013)
HPV: Diagnosis, Prevention, and Treatment
Jon K. Hathaway
CLINICAL OBSTETRICS AND GYNECOLOGY (2012)
The use of sinecatechins (polyphenon E) ointment for treatment of external genital warts
Eggert Stockfleth et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Emerging human papillomavirus vaccines
Barbara Ma et al.
EXPERT OPINION ON EMERGING DRUGS (2012)
Topical Imiquimod 5% cream therapy for external anogenital warts in pregnant women: Report of four cases and review of the literature
Andrea Ciavattini et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Role of regulatory T-cells in immunization strategies involving a recombinant alphavirus vector system
Mateusz Walczak et al.
ANTIVIRAL THERAPY (2011)
Cytoplasmic DNA innate immune pathways
Glen N. Barber
IMMUNOLOGICAL REVIEWS (2011)
Efficacy, safety and tolerability of green tea catechins in the treatment of external anogenital warts: a systematic review and meta-analysis
T. G. Tzellos et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Human Papillomavirus Vaccination Series Initiation and Completion, 2008-2009
Christina G. Dorell et al.
PEDIATRICS (2011)
Efficacy and Safety of Imiquimod Versus Podophyllotoxin in the Treatment of Anogenital Warts
Peter Komericki et al.
SEXUALLY TRANSMITTED DISEASES (2011)
New Approaches to Immunotherapy for HPV Associated Cancers
Anne-Sophie Bergot et al.
Cancers (2011)
Clinical management of HPV-related disease of the lower genital tract
M. Kyrgiou et al.
WOMEN'S HEALTH AND DISEASE (2010)
Immunotherapy for Cervical Cancer Research Status and Clinical Potential
Jun-Han Su et al.
BIODRUGS (2010)
Perspectives for Preventive and Therapeutic HPV Vaccines
Ken Lin et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2010)
Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7
Katsuyuki Adachi et al.
VACCINE (2010)
Surgery for cervical intraepithelial neoplasia
Pierre P. L. Martin-Hirsch et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
HPV and Therapeutic Vaccines: Where are We in 2010?
Barbara Ma et al.
CURRENT CANCER THERAPY REVIEWS (2010)
Interferon for the treatment of genital warts: a systematic review
Jin Yang et al.
BMC INFECTIOUS DISEASES (2009)
Adjuvant Photodynamic Therapy Does Not Prevent Recurrence of Condylomata Acuminata After Carbon Dioxide Laser Ablation-A Phase III, Prospective, Randomized, Bicentric, Double-Blind Study
Rolf-Markus Szeimies et al.
DERMATOLOGIC SURGERY (2009)
Different spectra of therapeutic vaccine development against HPV infections
Azam Bolhassani et al.
HUMAN VACCINES (2009)
Treatment With Cyclooxygenase-2 Inhibitors Enables Repeated Administration of Vaccinia Virus for Control of Ovarian Cancer
Chih-Long Chang et al.
MOLECULAR THERAPY (2009)
Evaluation of photodynamic therapy using topical aminolevulinic acid hydrochloride in the treatment of condylomata acuminata: a comparative, randomized clinical trial
Jun Liang et al.
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2009)
The first clinical use of a live-attenuated Listeria monocytogenes vaccine: A Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix
Paulo Cesar Maciag et al.
VACCINE (2009)
Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts - A randomized controlled trial
Silvio Tatti et al.
OBSTETRICS AND GYNECOLOGY (2008)
Listeria-based HPV-16 E7 vaccines limit autochthonous tumor growth in a transgenic mouse model for HPV-16 transformed tumors
Duane A. Sewell et al.
VACCINE (2008)
Screening and management of women and girls with human papillomavirus infection
Mark Spitzer
GYNECOLOGIC ONCOLOGY (2007)
Listeriolysin O: a phagosome-specific lysin
Pamela Schnupf et al.
MICROBES AND INFECTION (2007)
Vaccination with an adenoviral vector expressing calreticulin-human papillomavirus 16 E7 fusion protein eradicates E7 expressing established tumors in mice
Jorge G. Gomez-Gutierrez et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Comparison of the effectiveness of commonly used clinic-based treatments for external genital warts
Jackie Sherrard et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2007)
Comparative study of photodynamic therapy vs. CO2 laser vaporization in treatment of condylomata acuminata, a randomized clinical trial
K. Chen et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors:: Design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST)
Marie-Helene Mayrand et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Prime-boost vaccination strategy in women with high-grade, noncervical anogenital intraepithelial neoplasia: clinical results from a multicenter phase II trial
AN Fiander et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
The use of topical 5% imiquimod during pregnancy: A case series
A Einarson et al.
REPRODUCTIVE TOXICOLOGY (2006)
Liposome-polycation-DNA (LPD) particle as a carrier and adjuvant for protein-based vaccines: Therapeutic effect against cervical cancer
ZR Cui et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Vaccines against human papillomavirus and cervical cancer: Promises and challenges
A Mahdavi et al.
ONCOLOGIST (2005)
Cell-surface display of E7 antigen from human papillomavirus type-16 in Lactococcus lactis and in Lactobacillus plantarum using a new cell-wall anchor from lactobacilli
NG Cortes-Perez et al.
JOURNAL OF DRUG TARGETING (2005)
Therapeutic vaccines for cervical cancer: Dendritic cell-based immunotherapy
AD Santin et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Mechanisms of genomic instability in human cancer:: Insights from studies with human papillomavirus oncoproteins
S Duensing et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
SS Diebold et al.
SCIENCE (2004)
'State of the art' of radical hysterectomy; current practice in European oncology centres
JB Trimbos et al.
EUROPEAN JOURNAL OF CANCER (2004)
Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes
MC Cassetti et al.
VACCINE (2004)
ISCOMATRIX™ adjuvant:: an adjuvant suitable for use in anticancer vaccines
TJ Stewart et al.
VACCINE (2004)
Topical imiquimod 5% cream in external anogenital warts: A randomized, double-blind, placebo-controlled study
O Arican et al.
JOURNAL OF DERMATOLOGY (2004)
Mechanisms of human papillomavirus-induced oncogenesis
K Münger et al.
JOURNAL OF VIROLOGY (2004)
An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci
LG Bermúdez-Humarán et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2004)
Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts
CJN Lacey et al.
SEXUALLY TRANSMITTED INFECTIONS (2003)
Enhancing the immunogenicity of bioengineered Listeria monocytogenes by passaging through live animal hosts
C Peters et al.
VACCINE (2003)
External genital warts: Diagnosis, treatment, and prevention
DJ Wiley et al.
CLINICAL INFECTIOUS DISEASES (2002)
Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine
A de Jong et al.
VACCINE (2002)
Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides
S Zwaveling et al.
JOURNAL OF IMMUNOLOGY (2002)
Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8+ T-cell responses that home to the tumor site
A Lamikanra et al.
JOURNAL OF VIROLOGY (2001)
Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus
R Stratford et al.
VACCINE (2000)
Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice
M Dupuis et al.
JOURNAL OF IMMUNOLOGY (2000)
European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts
G von Krogh et al.
SEXUALLY TRANSMITTED INFECTIONS (2000)
Share Paper
